Anti-viral drug effective against coronavirus, study finds

Washington DC, Anti-viral drug remdesivir cuts recovery times in coronavirus patients.

Complete results from the research, which was carried out by US government agency the National Institute of Allergy and Infectious Diseases (NIAID), were published by leading medical periodical the New England Journal of Medicine.

The United States authorized the emergency use of remdesivir in hospitals on May 1, followed by Japan, while Europe is considering following suit.

The study found that remdesivir, injected intravenously daily for 10 days, accelerated the recovery of hospitalized COVID-19 patients compared to a placebo in clinical tests on just over a thousand patients across 10 countries.

NIAID director Anthony Fauci has said preliminary evidence indicated remdesivir had a “clear-cut, significant and positive effect in diminishing the time to recovery”.

कमेन्ट गर्नुहोस्